To enhance cisplatin response in HNSCC cells inhibited by EZH2, the following hypothesis has been proposed: H3K27 methylation, mediated by EZH2, serves as a marker of heterochromatin, which prevents external factors from accessing densely packed DNA. The gene discussed is EZH2; the disease is head and neck squamous cell carcinoma.